Abbott Laboratories EPS - Earnings per Share 2010-2024 | ABT

Abbott Laboratories earnings per share (EPS) for the twelve months ending June 30, 2024 was $3.17, a 8.19% increase year-over-year.

  • Abbott Laboratories EPS for the quarter ending June 30, 2024 was $0.74, a 5.13% decline year-over-year.
  • Abbott Laboratories 2023 annual EPS was $3.26, a 16.62% decline from 2022.
  • Abbott Laboratories 2022 annual EPS was $3.91, a 0.76% decline from 2021.
  • Abbott Laboratories 2021 annual EPS was $3.94, a 57.6% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Abbott Laboratories EPS - Earnings per Share 2010-2024 | ABT

  • Abbott Laboratories EPS for the quarter ending June 30, 2024 was $0.74, a 5.13% decline year-over-year.
  • Abbott Laboratories 2023 annual EPS was $3.26, a 16.62% decline from 2022.
  • Abbott Laboratories 2022 annual EPS was $3.91, a 0.76% decline from 2021.
  • Abbott Laboratories 2021 annual EPS was $3.94, a 57.6% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Stryker (SYK)$137.7B
Boston Scientific (BSX)$121.6B
Medtronic (MDT)$113B
EssilorLuxottica (ESLOY)$104.4B
Haleon (HLN)$48.1B
Lonza Group Ag (LZAGY)$45.4B
ResMed (RMD)$35B
Koninklijke Philips (PHG)$29B
Terumo (TRUMY)$27.9B
Zimmer Biomet Holdings (ZBH)$21.6B
Baxter (BAX)$20.1B
Insulet (PODD)$16.6B
Smith & Nephew SNATS (SNN)$13.4B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$9.2B
BellRing Brands (BRBR)$7.7B
Lantheus Holdings (LNTH)$7.5B
ICU Medical (ICUI)$4.3B
TG Therapeutics (TGTX)$3.9B
Haemonetics (HAE)$3.9B
Perrigo (PRGO)$3.8B
GN Store Nord (GNNDY)$3.8B
Neogen (NEOG)$3.7B
Prestige Consumer Healthcare (PBH)$3.6B
Envista Holdings (NVST)$3.3B
QuidelOrtho (QDEL)$3.1B
Agios Pharmaceuticals (AGIO)$2.6B
Maravai LifeSciences Holdings (MRVI)$2.3B
Green Thumb Industries (GTBIF)$2.2B
LeMaitre Vascular (LMAT)$2B